DPT looking to pick up where Ben Venue leaves off; AMRI names new discovery chief;

> Texas CMO DPT said it's getting calls from Ben Venue customers in search of a new partner once the troubled plant goes under. Article

> AMRI ($AMRI) has appointed Charles River Laboratories ($CRL) veteran Michael Luther to serve as senior vice president of its discovery segment. More

> Catalent has inked a deal with Coster to supply its pressurized metered dose inhalers. News

> Yale University's in-house research organization is conducting a trial of Halozyme Therapeutics' ($HALO) recombinant human hyaluronidase in Type 1 diabetes patients with closed-loop insulin pumps. Item